CERAMEDIX HOLDING, LLC

NEW YORK, NEW YORK 100223328

$5.19M
Total Contract Value
15 awards
First Award
May 20, 2022
Last Award
Sep 11, 2025
Business Size
other than small
CAGE Code
7SUF5

Top Industries (NAICS)

NAICS CodeObligationsAwards
541714$4.22M10
541715$03

Contract Awards

5 awards found

75N93023C00015
Department of Health and Human Services
$965K
Jun 27, 2025

DEVELOPMENT OF ANTICERAMIDE TREATMENT AS A NOVEL MEDICAL COUNTERMEASURE FOR ACUTE EFFECTS OF RADIATION EXPOSURE

NAICS: 541714 - RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)FY2025
75N93023C00015
Department of Health and Human Services
$302K
Feb 27, 2025

DEVELOPMENT OF ANTICERAMIDE TREATMENT AS A NOVEL MEDICAL COUNTERMEASURE FOR ACUTE EFFECTS OF RADIATION EXPOSURE

NAICS: 541714 - RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)FY2025
75N93023C00015
Department of Health and Human Services
$1.43M
Jun 13, 2024

DEVELOPMENT OF ANTICERAMIDE TREATMENT AS A NOVEL MEDICAL COUNTERMEASURE FOR ACUTE EFFECTS OF RADIATION EXPOSURE

NAICS: 541714 - RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)FY2024
75N93023C00015
Department of Health and Human Services
$100K
Aug 22, 2023

DEVELOPMENT OF ANTICERAMIDE TREATMENT AS A NOVEL MEDICAL COUNTERMEASURE FOR ACUTE EFFECTS OF RADIATION EXPOSURE

NAICS: 541714 - RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)FY2023
75N93023C00015
Department of Health and Human Services
$1.43M
Jun 29, 2023

DEVELOPMENT OF ANTICERAMIDE TREATMENT AS A NOVEL MEDICAL COUNTERMEASURE FOR ACUTE EFFECTS OF RADIATION EXPOSURE

NAICS: 541714 - RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)FY2023

Business Details

UEI
JLZSJRJVKJ49
CAGE Code
7SUF5
Address
555 MADISON AVE STE 1201
NEW YORK, NY 100223328
Congressional District
NY-12

Parent Company

CERAMEDIX HOLDING, LLC

Data Source

This profile is based on federal contract award data from USAspending.gov.

View on USAspending.gov